News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
Content Sharing
<Results> INNOCARE PHARMA (09969.HK) Achieves RMB642 Million Net Profit for Full Year, Turns Loss into Profit
INNOCARE PHARMA (09969.HK) announced its 2025 annual results, reporting revenue of RMB2.375 billion, representing a year-on-year increase of 135.3%. The company recorded a net prof...
Reset
Send
The window will close in 5 seconds
<Results> INNOCARE PHARMA (09969.HK) Achieves RMB642 Million Net Profit for Full Year, Turns Loss into Profit
Close
Recommend
4
Positive
8
Negative
1
 
 

INNOCARE PHARMA (09969.HK)  +0.660 (+4.441%)    Short selling $42.90M; Ratio 44.967%   announced its 2025 annual results, reporting revenue of RMB2.375 billion, representing a year-on-year increase of 135.3%. The company recorded a net profit of RMB642 million, compared to a loss of RMB441 million in the previous year, turning from loss to profit; earnings per share were RMB0.38. No final dividend was declared. (de/d)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

Dividend History
Announce DateEventParticular
2025/11/133rd QuarterlyNo Dividend
2025/08/19InterimNo Dividend
2025/05/131st QuarterlyNo Dividend
2025/03/27FinalNo Dividend



Related News G Sachs Slightly Raises TP for INNOCARE (09969.HK) to HKD19.93; Orelabrutinib Sales Steady Last Quarter
This article was automatically translated by AI, the Chinese version should be considered the authoritative version. AASTOCKS.com Limited does not guarantee its accuracy or completeness and accepts no liability for any damages or losses arising from the use of this translation.

Auto-translated by AI

AASTOCKS Financial News

Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.